Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Juraj Duras"'
Autor:
Heidi Mocikova, Jana Markova, Lubica Gaherova, Maria Maco, Alice Sýkorová, David Belada, Marie Lukášová, Vit Prochazka, Juraj Duras, Tomas Kozak
Publikováno v:
HemaSphere, Vol 6, Pp 11-12 (2022)
Externí odkaz:
https://doaj.org/article/535d17014f5a43eb85eafc11ad9b2654
Autor:
Heidi Mocikova, Robert Pytlík, Katerina Benesova, Andrea Janikova, Juraj Duras, Alice Sykorova, Katerina Steinerova, Vit Prochazka, Vit Campr, David Belada, Marek Trneny
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionWe analyzed the incidence, risk factors of central nervous system (CNS) relapse, and outcome of CNS involvement in patients with peripheral T-cell lymphomas (PTCL) from the Czech Lymphoma Study Group Registry NiHiL (Clinical Trial gov. NC
Externí odkaz:
https://doaj.org/article/de7be5e1b9b64877ad8935cf67565a06
Autor:
Prokop Vodicka, Katerina Benesova, Andrea Janikova, David Belada, Heidi Mocikova, Jan Pirnos, Vit Prochazka, Juraj Duras, Katerina Kopeckova, Katerina Steinerova, Petra Blahovcova, Vit Campr, Pavel Klener, Alice Sykorova, Marek Trneny
Publikováno v:
Blood. 140:3775-3776
Autor:
Mehdi Hamadani, Morton Coleman, Ralph Boccia, Juraj Duras, Martin Hutchings, Pier Luigi Zinzani, Raul Cordoba, Mariana Bastos Oreiro, Wei Jiang, Michael Stouffs, Peter Langmuir, Juan-Manuel Sancho
Publikováno v:
Transplantation and Cellular Therapy. 28:S407-S408
Autor:
J. Dlouha, Heidi Mocikova, Vít Procházka, A. Sykorova, David Belada, Kateřina Steinerová, Marek Trneny, K Benesova, Andrea Janíková, Vit Campr, Robert Pytlik, Juraj Duras
Publikováno v:
Hematological Oncology. 39
Autor:
Juraj Duras, Roman Hájek, Michal Kaščák, Hana Plonkova, Katerina Benkova, Zdenek Koristek, Tereza Popkova, Michal Simicek, Lucie Cerna, Tomas Jelinek, Jana Mihalyova
Publikováno v:
Hematological oncology. 38(3)
Autor:
Jozef Michalka, Vít Procházka, Zbynek Bortlicek, Natasa Kopalova, Andrea Janíková, Jan Pirnos, David Belada, Marek Trneny, Heidi Mocikova, Pavel Klener, Jitka Hamouzova, Katerina Benesova, Renata Chloupková, Vit Campr, Robert Pytlik, Juraj Duras
Publikováno v:
Annals of hematology. 99(7)
Relapsing diffuse large B cell lymphomas (rDLBCL) represent a heterogeneous disease. This heterogeneity should be recognized and reflected, because it can deform the interpretation of clinical trial results. DLBCL patients with the first relapse and
Autor:
Andrea Janíková, Michaela Hamouzova, Marek Trneny, Samuel Vokurka, Jiri Mayer, Jan Pirnos, Heidi Mocikova, Natasa Kopalova, Vít Procházka, Zbynek Bortlicek, Robert Pytlik, Vit Campr, Juraj Duras, Katerina Benesova, David Belada
Publikováno v:
Annals of Hematology. 97:669-678
The aim of this study is to assess the incidence, risk factors, and outcome of biopsy-proven transformation in follicular lymphoma (FL) patients in the rituximab era. Transformation was analyzed in 1233 patients with initially diagnosed FL grades 1
Autor:
Pavel Klener, Heidi Mocikova, Natasa Kopalova, Jan Pirnos, Marek Trneny, Vít Procházka, Renata Chloupková, Vit Campr, Juraj Duras, David Belada, K Benesova, Andrea Janíková, A. Sykorova, Jitka Hamouzova
Publikováno v:
Hematological Oncology. 37:465-467
Autor:
Jana Mihalyova, Michal Simicek, Zdenek Koristek, J. Gumulec, Martin Havel, Lucie Huvarova, Juraj Duras, Jana Zuchnická, Tereza Popkova, Lucie Broskevicova, Roman Hájek, Hana Plonkova, Katerina Growkova, Petra Richterova, Bruno Paiva, Michal Kaščák, Milan Navrátil, Lucie Cerna, Tomas Jelinek, Katerina Benkova
Publikováno v:
American journal of hematology. 94(1)